FOLFOXIRI plus bevacizumab as standard of care for first-line treatment in patients with advanced colon cancer

  1. Cervantes, A.
  2. Prager, G.W.
Zeitschrift:
ESMO Open

ISSN: 2059-7029

Datum der Publikation: 2023

Ausgabe: 8

Nummer: 2

Art: Verlag

DOI: 10.1016/J.ESMOOP.2023.100883 GOOGLE SCHOLAR lock_openOpen Access editor